Adjustable Artificial Chordae Tendineae Fixing Assembly

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current percutaneous mitral repair techniques, such as MitraClip, cannot effectively implant and adjust the length of artificial chordae tendineae, leading to non-physiological repairs and increased surgical trauma, while existing implantation methods face challenges in adjusting the length of artificial chordae tendineae post-surgery due to cardiac volume changes.

Innovation Solution

An adjustable artificial chordae tendineae fixing assembly comprising an occlusion device with a penetrating passage and adjusting rod, featuring a locking assembly with friction plates and magnetic clamping jaws, allowing for repeated adjustment of the chordae tendineae length by controlling the friction plates and using magnetic attraction for secure clamping.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If percutaneous approach is used to implant artificial chordae tendineae, then surgical trauma is reduced, but the ability to adjust chordae length after implantation is lost

Engineering Contradiction:
Improvesurgical traumaVSAvoidadjustability of chordae length
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The fixing assembly incorporates an adjustable structure that allows the chordae length to be modified after implantation. The assembly includes a movable component that can be repositioned along the chordae to change the effective length, enabling dynamic adaptation to cardiac volume changes and anatomical variations post-surgery.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The fixing assembly acts as an intermediary device between the chordae and the heart tissue. It provides a interface that allows both secure fixation and subsequent adjustment, mediating between the need for stable implantation and the requirement for post-implantation adaptability.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If artificial chordae tendineae are fixed using traditional methods, then implantation is simplified, but the chordae length cannot be adjusted after surgery

Engineering Contradiction:
Improvesimplicity of implantationVSAvoidpost-surgery adjustment capability
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The fixing assembly transforms a static fixation device into a dynamic one with adjustment capabilities. The design allows for initial simple implantation followed by controlled adjustment through a mechanism that can be actuated externally or internally to modify the chordae length.

Inventive Principle:
Principle #15Dynamics

3Reliability

If open mitral valvuloplasty is performed, then effective treatment of mitral regurgitation is achieved, but surgical trauma and postoperative complications increase

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidsurgical trauma and complications
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The percutaneous fixing assembly serves as an intermediary that enables effective mitral valve repair without requiring open surgery. It delivers the chordae implantation function through a minimally invasive access route, maintaining treatment effectiveness while avoiding the trauma associated with traditional open approaches.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention replaces the mechanical open surgical system with a percutaneous delivery system. The fixing assembly is delivered through a catheter-based approach, substituting the need for large incisions and direct surgical manipulation with a less invasive mechanical delivery mechanism.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables safe, minimally invasive fixation and repeated adjustment of artificial chordae tendineae length, reducing surgical trauma and addressing length changes post-surgery, thereby improving the efficacy of mitral valve repair procedures.

Implementation Method 1

A locking assembly and a plurality of friction plates on the inner side of the adjusting device extend inside the opening of the penetrating passage. The plurality of friction plates are connected to the valve, and the number of the plurality of friction plates is at least two. The plurality of friction plates are controlled to be opened or closed by rotating the valve, so as to control the penetrating passage to be opened or closed.

Methodology Applied
Scientific EffectFriction: Friction

Implementation Method 2

The occlusion device is an elastic mesh structure capable of producing an elastic deformation.

Methodology Applied
Scientific EffectElastic deformation: Elasticity

Implementation Method 3

Two clamping jaws are arranged at the head of the adjusting rod, and the two clamping jaws are connected to a handle at the tail of the adjusting rod by a spring. The two clamping jaws are controlled to be opened and closed by pressing the handle at the tail of the adjusting rod.

Methodology Applied
Scientific EffectSpring force: Spring

Implementation Method 4

The two clamping jaws can be clamped on the protruding portion of the adjusting device to be connected to the occlusion device.

Methodology Applied
Scientific EffectMagnetic attraction: Magnetism

Data Source

PatentUS11331188B2Adjustable artificial chordae tendineae fixing assembly and an implanting method thereof
Publication Date: 2022.05.17 TAN XIONGJIN
  • US11331188B2 patent drawing
  • US11331188B2 patent drawing
  • US11331188B2 patent drawing

AI summary

An adjustable artificial chordae tendineae fixing assembly includes an occlusion device and an adjusting rod which are both a hollow structure allowing the artificial chordae tendineae to pass through. The occlusion device is configured to be clamped on the interventricular septum. The occlusion device is provided with a switch adjusting device which controls the artificial chordae tendineae to move and to be fixed. The adjusting rod is connected to the occlusion device, and is capable of repeatedly adjusting the switch adjusting device on the occlusion device. The artificial chordae tendineae fixing assembly can fix the artificial chordae tendineae on the interventricular septum, and can also overcome the problem of unsuitable length of the artificial chordae tendineae in most of patients after the procedure due to cardiac changes. The artificial chordae tendineae is retained at the skin puncture point for a short time.